as 06-18-2025 4:00pm EST
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
Founded: | 2014 | Country: | United States |
Employees: | N/A | City: | SOUTH SAN FRANCISCO |
Market Cap: | 362.9M | IPO Year: | 2020 |
Target Price: | $18.83 | AVG Volume (30 days): | 2.0M |
Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.88 | EPS Growth: | N/A |
52 Week Low/High: | $3.90 - $14.67 | Next Earning Date: | 08-11-2025 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Piscitelli Dominic | ORIC | Chief Financial Officer | Jun 6 '25 | Sell | $10.00 | 2,900 | $29,021.32 | 104,164 |
ORIC Breaking Stock News: Dive into ORIC Ticker-Specific Updates for Smart Investing
Zacks
6 days ago
TipRanks
6 days ago
GlobeNewswire
13 days ago
Zacks
17 days ago
Zacks
21 days ago
MT Newswires
21 days ago
Insider Monkey
21 days ago
MT Newswires
22 days ago
The information presented on this page, "ORIC Oric Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.